Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM
· Real-Time Price · USD
3.01
-0.30 (-9.06%)
At close: Sep 25, 2025, 3:59 PM
3.01
0.03%
After-hours: Sep 25, 2025, 05:16 PM EDT
-9.06% (1D)
| Bid | 3 |
| Market Cap | 2.15M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.33M |
| EPS (ttm) | 41.76 |
| PE Ratio (ttm) | 0.07 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.13 |
| Volume | 184,436 |
| Avg. Volume (20D) | 2,075,833 |
| Open | 3.35 |
| Previous Close | 3.31 |
| Day's Range | 3.01 - 3.60 |
| 52-Week Range | 2.36 - 82.80 |
| Beta | 0.18 |
| Ex-Dividend Date | n/a |
1 month ago
-6.85%
PBM stock has given up its prior gain. Psyence Bio...
Unlock content with
Pro Subscription
1 month ago
-6.85%
Psyence Biomedical shares are trading higher after the company announced it, along with PsyLabs, achieved a breakthrough in GMP-aligned high-purity ibogaine production.
